Showing results (181-190 of 2,208) with videos related to

Sort By:
Pageof 221
Kyobu Geka. the Japanese Journal of Thoracic Surgery|February 26, 1999
[Two cases of descending necrotizing mediastinitis]K Sato, Y Sato, K Yoshiya, et al.
European Journal of Endocrinology|May 1, 1996
Adrenocorticotropin-independent bilateral macronodular adrenocortical hyperplasia: immunohistochemical studies of steroidogenic enzymes and post-operative course in two menN Wada, M Kubo, H Kijima, et al.
Biochemical and Biophysical Research Communications|March 10, 2001
Identification of a potent and nonpeptidyl ccr3 antagonistT Saeki, K Ohwaki, A Naya, et al.
Gan No Rinsho. Japan Journal of Cancer Clinics|September 1, 1986
[Intracavitary administration of recombinant interferon in cancer patients with malignant effusions]S Takashima, T Saeki, H Saeki, et al.
Japanese Journal of Pharmacology|June 1, 1991
The inhibitory effect of a novel antiatheromatous agent, E5050, on the intimal thickening of aorta in cholesterol-fed rabbit in vivoT Saeki, I Ohtsuka, R Hashida, et al.
Gan No Rinsho. Japan Journal of Cancer Clinics|April 1, 1986
[Clinicopathological studies on cases of multiple primary carcinomas of the esophagus associated with carcinoma of the hypopharynx and cervical esophagus]W Takiyama, Y Yamaguch, T Saeki, et al.
Ryumachi. [Rheumatism]|March 1, 2000
[Two cases of silicosis exhibiting MPO-ANCA associated disorder]H Kourakata, T Saeki, S Miyamura, et al.
Journal of Lipid Research|July 7, 2000
Effect of ER-27856, a novel squalene synthase inhibitor, on plasma cholesterol in rhesus monkeys: comparison with 3-hydroxy-3-methylglutaryl-coa reductase inhibitorsH Hiyoshi, M Yanagimachi, M Ito, et al.
Journal of Nutritional Science and Vitaminology|July 8, 2000
Antitumorigenic effects of several food proteins in a rat model with colon cancer and their reverse correlation with plasma bile acid concentrationN Azuma, H Suda, H Iwasaki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 17, 2000
[Combination chemotherapy with vinorelbine and other cytotoxic agents for advanced breast cancer patients--a protocol of vinorelbine plus AC regimens used by the Japan Vinorelbin Study Group]T Saeki, I Adachi, M Ogita, et al.
Pageof 221